BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18430526)

  • 1. Testing the efficacy of medium chain fatty acids against rabbit colibacillosis.
    Gallois M; Gidenne T; Orengo J; Caubet C; Tasca C; Milon A; Boullier S
    Vet Microbiol; 2008 Sep; 131(1-2):192-8. PubMed ID: 18430526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infection.
    Gallois M; Gidenne T; Tasca C; Caubet C; Coudert C; Milon A; Boullier S
    Clin Vaccine Immunol; 2007 May; 14(5):585-92. PubMed ID: 17344351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible influence of LuxS in the in vivo virulence of rabbit enteropathogenic Escherichia coli.
    Zhu C; Feng S; Sperandio V; Yang Z; Thate TE; Kaper JB; Boedeker EC
    Vet Microbiol; 2007 Dec; 125(3-4):313-22. PubMed ID: 17643872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain.
    Zhu C; Feng S; Thate TE; Kaper JB; Boedeker EC
    Vaccine; 2006 May; 24(18):3845-55. PubMed ID: 16112258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A directed intimin insertion mutant of a rabbit enteropathogenic Escherichia coli (REPEC) is attenuated, immunogenic and elicits serogroup specific protection.
    Ahmed S; Byrd W; Kumar S; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):146-55. PubMed ID: 23084628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inactivation of espB and tir abrogates the strong, but non-protective, inflammatory response induced by EPEC.
    Lefoll C; Caubet C; Tasca C; Milon A; Boullier S
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):34-44. PubMed ID: 20633933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of caprylic acid and triacylglycerols of both caprylic and capric acid in rabbits experimentally infected with enteropathogenic Escherichia coli O103.
    Skrivanová E; Molatová Z; Marounek M
    Vet Microbiol; 2008 Jan; 126(4):372-6. PubMed ID: 17703901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge.
    Boullier S; Nougayrède JP; Marchès O; Tasca C; Boury M; Oswald E; De Rycke J; Milon A
    Microbes Infect; 2003 Aug; 5(10):857-67. PubMed ID: 12919854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activity of rabbit milk and medium-chain fatty acids against enteropathogenic Escherichia coli O128.
    Skrivanová E; Molatová Z; Skrivanová V; Marounek M
    Vet Microbiol; 2009 Mar; 135(3-4):358-62. PubMed ID: 19019572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New flow cytometric method to quantify the inhibition of enteropathogenic Escherichia coli adhesion by anti-adhesin antibodies.
    Boullier S; Tasca C; Milon A
    Cytometry A; 2003 Jun; 53(2):79-87. PubMed ID: 12766969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral infection with enteropathogenic Escherichia coli triggers immune response and intestinal histological alterations in mice selected for their minimal acute inflammatory responses.
    Vulcano AB; Tino-De-Franco M; Amaral JA; Ribeiro OG; Cabrera WH; Bordenalli MA; Carbonare CB; Álvares EP; Carbonare SB
    Microbiol Immunol; 2014 Jun; 58(6):352-9. PubMed ID: 24750489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of antibiotic resistance in enteropathogenic Escherichia coli carrying extended-spectrum beta-lactamases recovered from diarrhoeic rabbits.
    Poeta P; Radhouani H; Gonçalves A; Figueiredo N; Carvalho C; Rodrigues J; Igrejas G
    Zoonoses Public Health; 2010 May; 57(3):162-70. PubMed ID: 19309480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice.
    Manthey CF; Autran CA; Eckmann L; Bode L
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):165-8. PubMed ID: 24048169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diarrheagenic Escherichia coli pathotypes investigation revealed atypical enteropathogenic E. coli as putative emerging diarrheal agents in children living in Botucatu, São Paulo State, Brazil.
    Dias RC; Dos Santos BC; Dos Santos LF; Vieira MA; Yamatogi RS; Mondelli AL; Sadatsune T; Sforcin JM; Gomes TA; Hernandes RT
    APMIS; 2016 Apr; 124(4):299-308. PubMed ID: 26752102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit EPEC: a model for the study of enteropathogenic Escherichia coli.
    Milon A; Oswald E; De Rycke J
    Vet Res; 1999; 30(2-3):203-19. PubMed ID: 10367355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103.
    Heczko U; Carthy CM; O'Brien BA; Finlay BB
    Infect Immun; 2001 Jul; 69(7):4580-9. PubMed ID: 11402002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of rabbits against enteropathogenic Escherichia coli (EPEC) using an intimin null mutant.
    Stakenborg T; Vandekerchove D; Mariën J; Laevens H; Imberechts H; Peeters J
    BMC Vet Res; 2006 Jun; 2():22. PubMed ID: 16796739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
    Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
    Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccination of weaned rabbits against enteropathogenic Escherichia coli-like E. coli O103 infection: use of heterologous strains harboring lipopolysaccharide or adhesin of pathogenic strains.
    Milon A; Esslinger J; Camguilhem R
    Infect Immun; 1992 Jul; 60(7):2702-9. PubMed ID: 1351880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges.
    Liu J; Wang WD; Liu YJ; Liu S; Zhou B; Zhu LW; Ji X; Sun Y; Feng SZ
    Lett Appl Microbiol; 2012 Mar; 54(3):255-62. PubMed ID: 22211792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.